SCHEMBL7128074

SCHEMBL7128074

CN1CC=C(Cc2ccc(Cl)nc2)C1=S

nearest known ligand 0.55

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7122899 0.71 GAA (0.37) LMNAL3MBTL1ALDH1A1
SCHEMBL7008231 0.71 CHRNA1 (0.50) MEN1KMT2AATM
SCHEMBL7007394 0.69 CHRNA1 (0.45) ALDH1A1
SCHEMBL9025074 0.65 LMNA (0.42) LMNAL3MBTL1ALDH1A1MEN1KMT2A
Iodide SCHEMBL7129576 0.63 MEN1 (0.38) ALDH1A1MEN1KMT2AATM
SCHEMBL91385 0.63
SCHEMBL453213 0.63
SCHEMBL29609117 0.62 KDM4E (0.59) LMNAL3MBTL1ALDH1A1
SCHEMBL2600059 0.62 ALDH1A1 (0.61) LMNAL3MBTL1ALDH1A1
SCHEMBL2125695 0.62 KDM4E (0.59) LMNAL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6664248-B2 Well tolerated by animals, fish and plants SYNGENTA INVESTMENT CORP. 2003-12-16 US disclosed
US-20030166635-A1 Novel 2-nitromethylidene/2-cyanimino/2-nitro-imino-pyrrolidines and piperidines, intermediates, and their use as pesticides MAIENFISCH PETER (CH) 2003-09-04 US disclosed
US-6506743-B2 Especially for controlling insects. SYNGENTA INVESTMENT CORPORATION 2003-01-14 US disclosed
US-20020068733-A1 Novel 2-nitromethylidene/2-cyanimino/2-nitro-imino-pyrrolidines and piperidines, intermediates, and their use as pesticides MAIENFISCH PETER (CH) 2002-06-06 US disclosed
US-6353001-B1 PESTICIDES, INSECTICIDES, APHIDICIDES AND LARVICIDES SYNGENTA INVESTMENT CORPORATION 2002-03-05 US disclosed
EP-0693066-B1 2-NITROMETHYLIDENE/2-CYANIMINO/2-NITRO-IMINO-PYRROLIDINES AND PIPERIDINES, INTERMEDIATES, AND THEIR USE AS PESTICIDES SYNGENTA PARTICIPATIONS AG (CH) 2001-05-16 EP disclosed
US-6048824-A 2-nitromethylidene/2-cyanimino/2-nitro-imino-pyrrolidines and piperidines, intermediates, and their use as pesticides NOVARTIS CORPORATION (US) 2000-04-11 US disclosed
EP-0693066-A1 NOVEL 2-NITROMETHYLIDENE/2-CYANIMINO/2-NITRO-IMINO-PYRROLIDINES AND PIPERIDINES, INTERMEDIATES, AND THEIR USE AS PESTICIDES Novartis AG (CH) 1996-01-24 EP disclosed
WO-1994024124-A1 NOVEL 2-NITROMETHYLIDENE/2-CYANIMINO/2-NITRO-IMINO-PYRROLIDINES AND PIPERIDINES, INTERMEDIATES, AND THEIR USE AS PESTICIDES CIBA-GEIGY AG (CH) 1994-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020068733-A1 Novel 2-nitromethylidene/2-cyanimino/2-nitro-imino-pyrrolidines and piperidines, intermediates, and their use as pesticides HCN1, HCN2, CNTN1 LMNA 1221/4885L3MBTL1 3309/4885ALDH1A1 1215/4885
US-20030166635-A1 Novel 2-nitromethylidene/2-cyanimino/2-nitro-imino-pyrrolidines and piperidines, intermediates, and their use as pesticides HCN1, HCN2, CNTN1 LMNA 1152/4885L3MBTL1 3389/4885ALDH1A1 1308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.